HEALTHSTREAM INC (HSTM)
Health Care · Healthcare Software / Workforce Management · NASDAQ
HealthStream offers an essential SaaS platform for healthcare workforce development, clinical education, and administrative credentialing.
What HEALTHSTREAM INC does
HealthStream provides a suite of software-as-a-service (SaaS) solutions designed for the healthcare industry to manage workforce development, clinical education, and credentialing. Its platform helps healthcare organizations maintain compliance, improve clinical outcomes, and streamline administrative processes for their staff. The company serves the market through a focus on professional development, competence assessment, and provider enrollment services.
Themes: healthcare IT, workforce management, SaaS, healthcare compliance, clinical education
Fundamentals
- Price$32.47 as of 2026-10-08 close
- Market cap$949M as of 2026-08-03 (share count; price 2026-10-08)
- 1-year return+19.5% 2025-10-08 close $27.18 → 2026-10-08 close $32.47
- P/E45.24 as of 2026-10-08
- Net margin+6.0% FY2025, SEC XBRL
- ROE+5.2% FY2025, SEC XBRL
- Debt / equity0.00 as of 2026-09-03
- Revenue growth (YoY)+8.8% as of 2026-09-03
- Revenue CAGR (3y)+4.5% SEC XBRL
- Beta0.50 as of 2026-09-03
- Last reported earnings2026-08-03 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +0.5%; 3-year non-decreasing per-share dividend streak (SEC XBRL).
How HSTM compares in its sector
- price-to-earnings ratiomiddle range 185 covered Health Care peers, as of 2026-10-08
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-03
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-03
- return on equitymiddle range 510 covered Health Care peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- indicated dividend yieldbottom 25% 72 covered Health Care peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, HSTM's dividend was covered by reported results (earnings payout 20%, free-cash-flow payout 6%). This describes past coverage, not a forecast.
- Earnings payout20% dividends / net income
- Free-cash-flow payout6% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How HEALTHSTREAM INC looks technically
HEALTHSTREAM INC (HSTM) is trading 31.6% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 71 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 38, with buyers in control. Momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 77, in overbought territory (above 70). MACD, a trend-momentum gauge, turned bullish about 7 trading days ago (its momentum flipped positive). It just made a new 20-day high, pushing above its recent trading range. It is trading right at its highest price of the past year (its 52-week high).
Trend
8
| Distance from the 200-day | it is trading 31.6% above its 200-day average, the long-term trend line — a longer-term uptrend | +31.6% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $29.25 | $29.25 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $24.68 | $24.68 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 23 calendar days ago — the swings before that are what the structure reading is measured on | 23 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 30.3. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible upward five-wave sequence, in wave 4 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 71 trading days ago — a "golden cross", a bullish long-term signal | 71 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 38, with buyers in control | 37.6 |
Momentum
3
| 14-day RSI | momentum is stretched — its 14-day RSI (a 0–100 momentum gauge) is 77, in overbought territory (above 70) | 77.4 |
|---|---|---|
| Position in its 14-day range | it is trading right at the top of its 14-day range ($28.56 to $32.50) — its "stochastic" reading is 99 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 99.2 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 7 trading days ago (its momentum flipped positive) | 7 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $32.50 | $32.50 |
|---|---|---|
| From the 52-week high | it is trading right at its highest price of the past year (its 52-week high) | -0.1% |
| Above the 52-week low | it is 66.5% above its 52-week low (its lowest price of the past year) | +66.5% |
| Below the 52-week high | it is at or near its highest point of the past year | 0.1% |
| Since a 20-day breakout | it just made a new 20-day high, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day high, pushing above its recent trading range | 1 session |
| All-time high | its highest closing price on record is $39.77 (set on 2013-10-18) | $39.77 |
| Given back of the 52-week move | over the past year its closes ranged ($19.88 to $32.47), and it has given back essentially none of its rise from last year’s low — 0% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $24.29 to $24.69. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 0.0% |
| From the all-time high | it is 18.4% below its all-time high | -18.4% |
| Nearest price level | it is trading 0.7% below a resistance level at $32.70 — a price it turned at three times since 2024-11-13, most recently on 2025-04-03. Since 2024-10-08 it has 15 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.7% |
| All-time low | its lowest closing price on record is $1.00 (set on 2010-05-06) | $1.00 |
| Above the all-time low | it is 3147.0% above its all-time low | +3,147% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are wider than usual versus its own recent 6-month history (wider than about 71% of it) | 71st percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.7666 between its high and its low — about 2.4% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.7666 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $27.71 and $32.11 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $27.71 – $29.91 – $32.11 |
| Typical daily range (% of price) | its price moves about 2.4% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.4% |
| Stretch from the 200-day average | it is trading 10.2 daily ranges above its 200-day average price (31.6% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 10.2 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.99× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
2
| Since a doji | 6 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 6 sessions ago |
|---|---|---|
| Since a bullish engulfing | 1 session ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 1 session ago |
Price gaps
1
| Gap at the open | it opened on 2026-10-08 at essentially the same price it closed at the session before — no meaningful overnight gap | 0.0% |
|---|
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +3.7% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 12.0 percentage points (the stock gained 13.1% while the market gained 1.0%) | +12.0% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 11.4 percentage points (the stock gained 15.2% while the market gained 3.8%) | +11.4% |
| vs market, 6 months | over the past 6 months this stock beat the market by 41.7 percentage points (the stock gained 59.2% while the market gained 17.5%) | +41.7% |
| vs market, 12 months | over the past 12 months this stock beat the market by 4.5 percentage points (the stock gained 19.5% while the market gained 15.0%) | +4.5% |
Signal agreement
2
| Bullish technical signals | 7 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, a strong uptrend, with buyers in control, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 7 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: its RSI momentum gauge is overbought (a stretched reading), near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 11% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 2.9% of the share price. | +11.5% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 35% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $24.06 — a volume-weighted average of daily closes over 190 sessions, not a true tick-by-tick VWAP. | +35.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 11% above the average price paid since it last reported on 2026-08-03 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $29.30 — a volume-weighted average of daily closes over 48 sessions, not a true tick-by-tick VWAP. | +10.8% |
Price levels it has turned at before
HSTM last closed at $32.47 on 2026-10-08. Since 2024-10-08 it has turned at 15 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $32.70 | Resistance | 0.7% above the last close | turned there three times · 2024-11-13 to 2025-04-03 |
| $31.24 | Support | 3.8% below the last close | turned there three times · 2024-11-15 to 2026-08-04 |
| $34.15 | Resistance | 5.2% above the last close | turned there three times · 2025-02-14 to 2025-05-02 |
| $30.58 | Support | 5.8% below the last close | turned there six times · 2024-10-22 to 2026-09-03 |
| $29.82 | Support | 8.2% below the last close | turned there five times · 2025-04-07 to 2026-09-15 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $30.30.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $29.52 and $30.30 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 6 trading days, since 2026-10-01.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Overbought (14-day RSI above 70) · Near the 52-week high · Broke out to a new 20-day high · in a strong, established uptrend (ADX) · beating the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (2.20 mean, 1=Strong Buy…5=Strong Sell) — 2 analysts
- Mean price target$34.50 range $29.00 – $40.00
Analyst estimates, as of 2026-10-09. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for HSTM
- Consensus EPS estimate$0.14 next reporting period, as of 2026-10-09
- Estimate change, 30 days$0.00 (0.0%) from $0.14, on 2026-09-04, 35-day window
- Readings revised upward0% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependency on healthcare industry spending and budget constraints.","Integration and performance risks related to acquired businesses and software.","Highly competitive environment for healthcare software and workforce solutions."]
What changed in the latest 10-Q
AI-assisted comparison of HSTM's 10-Q filed 2026-05-06 against the prior one filed 2025-11-06.
Management's Discussion & Analysis (MD&A)
- Reworded:
- Reference year changed from 'December 31, 2024' (older, filed 2025-11-06) to 'December 31, 2025' (newer, filed 2026-05-06)
- Form 10-K filing date changed from 'February 28, 2025' (older, filed 2025-11-06) to 'February 26, 2026' (newer, filed 2026-05-06)
- Form 10-K reference changed from '2024 Form 10-K' (older, filed 2025-11-06) to '2025 Form 10-K' (newer, filed 2026-05-06)
- Phrase 'may cause the Company's actual results' (newer, filed 2026-05-06) replaced 'may cause actual results' (older, filed 2025-11-06) - added 'the Company's'
- Notes:
- Text appears truncated at 'caption Part I,' in both versions; full section not available for complete comparison
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 1 open-market sale by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
- Last 30 days · read to 2026-10-040 buys · 1 sell ($4M) — 1 selling insider
- Last 90 days · read to 2026-10-040 buys · 1 sell ($4M) — 1 selling insider
- Last 180 days · read to 2026-10-040 buys · 5 sells ($5M) — 3 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-14. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about HSTM's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding HSTM as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 5,694,892
- Reported value $155,185,814
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 2 increased, 3 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about HSTM's institutional holders → See what each manager we track holds →
Short interest (FINRA)
HSTM had 1,294,069 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
HSTM had 4.43% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 6.31 days to cover at the same settlement.
- Reported short interest (shares) 1,294,069
- Short interest (% of shares outstanding) 4.43%
- Prior settlement (shares) 1,360,125
- Reported change -4.86%
- Days to cover (reported) 6.31
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- RLDatix
- Symplr
- Relias (Bertelsmann)
- Cornerstone OnDemand
- Workday (WDAY)
- Oracle (ORCL)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare HSTM vs…
HEALTHSTREAM INC is found in…
Frequently asked questions
What does HEALTHSTREAM INC (HSTM) do?
HealthStream provides a suite of software-as-a-service (SaaS) solutions designed for the healthcare industry to manage workforce development, clinical education, and credentialing. Its platform helps healthcare organizations maintain compliance, improve clinical outcomes, and streamline administrative processes for their staff. The company serves the market through a focus on professional development, competence assessment, and provider enrollment services.
What sector is HEALTHSTREAM INC (HSTM) in?
HEALTHSTREAM INC (HSTM) is classified in the Health Care sector. Its industry is Healthcare Software / Workforce Management. It trades on NASDAQ.
Does HSTM pay a dividend?
Yes — HEALTHSTREAM INC (HSTM) pays a dividend, with an indicated yield of about 0.55% and 3-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-09-03). Informational only — not financial advice.
Who are HEALTHSTREAM INC's (HSTM) competitors?
Notable peers of HEALTHSTREAM INC (HSTM) include RLDatix, Symplr, Relias (Bertelsmann), Cornerstone OnDemand and Workday. This peer set is informational only — not financial advice.
Is HEALTHSTREAM INC (HSTM) overbought or oversold right now?
HEALTHSTREAM INC (HSTM) is currently in overbought territory (its 14-day RSI is 77, above 70) (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on HSTM come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.